(ATLN:SIX SWISS EXCHANGE AG)
Chief Scientific Officer, Senior Vice President and Member of the Management Board, Actelion Ltd.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 2 different industries.|
Mr. Martine Clozel founded Actelion Pharmaceuticals U.S., Inc. in 1997 and serves as its Chief Scientific Officer, Senior Vice President and Head of Drug Discovery Pharmacology & Preclinical Development. Ms. Clozel has been Senior Vice President of Actelion Ltd. since 1997 and serves as its Member of the Management Board. She has been Chief Scientific Officer of Actelion Ltd., since April 2009 and served as its Head of Drug Discovery Pharmacologa & Preclinical Development. ...
Gewerberstrasse 16Phone: 41 61 565 65 65
Allschwil, Basel-Landschaft 4123
Fax: 41 61 565 65 00
Board Members Memberships*There is no Board Members Memberships data available.
University of California-San Francisco
Université Nancy 2
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Marc M.P. de Garidel||Chairman, Chief Executive Officer and Member of Strategic Committee|
|Giovanni Recordati||Chairman, Chief Executive Officer and General Manager|
|Jean-Christophe Tellier||Chief Executive Officer and Executive Director|
|Jörg-Thomas Dierks||Chief Executive Officer|
|kr2.1M||Compensation as of Fiscal Year 2013.|